These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 22178551)
1. A multivalent approach to the discovery of long-acting β(2)-adrenoceptor agonists for the treatment of asthma and COPD. Jacobsen JR; Choi SK; Combs J; Fournier EJ; Klein U; Pfeiffer JW; Thomas GR; Yu C; Moran EJ Bioorg Med Chem Lett; 2012 Jan; 22(2):1213-8. PubMed ID: 22178551 [TBL] [Abstract][Full Text] [Related]
2. Discovery of TD-4306, a long-acting β2-agonist for the treatment of asthma and COPD. McKinnell RM; Klein U; Linsell MS; Moran EJ; Nodwell MB; Pfeiffer JW; Thomas GR; Yu C; Jacobsen JR Bioorg Med Chem Lett; 2014 Jul; 24(13):2871-6. PubMed ID: 24835980 [TBL] [Abstract][Full Text] [Related]
3. Multivalent design of long-acting β(2)-adrenoceptor agonists incorporating biarylamines. Jacobsen JR; Aggen JB; Church TJ; Klein U; Pfeiffer JW; Pulido-Rios TM; Thomas GR; Yu C; Moran EJ Bioorg Med Chem Lett; 2014 Jun; 24(12):2625-30. PubMed ID: 24813741 [TBL] [Abstract][Full Text] [Related]
4. The discovery of indole-derived long acting beta2-adrenoceptor agonists for the treatment of asthma and COPD. Brown AD; Bunnage ME; Glossop PA; Holbrook M; Jones RD; Lane CA; Lewthwaite RA; Mantell S; Perros-Huguet C; Price DA; Webster R Bioorg Med Chem Lett; 2007 Nov; 17(22):6188-91. PubMed ID: 17897826 [TBL] [Abstract][Full Text] [Related]
5. Dual β2-adrenoceptor agonists-PDE4 inhibitors for the treatment of asthma and COPD. Shan WJ; Huang L; Zhou Q; Jiang HL; Luo ZH; Lai KF; Li XS Bioorg Med Chem Lett; 2012 Feb; 22(4):1523-6. PubMed ID: 22297114 [TBL] [Abstract][Full Text] [Related]
6. Beta-adrenoceptor responses of the airways: for better or worse? Broadley KJ Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310 [TBL] [Abstract][Full Text] [Related]
7. (R)-salbutamol in the treatment of asthma and chronic obstructive airways disease. Patel M; Thomson NC Expert Opin Pharmacother; 2011 May; 12(7):1133-41. PubMed ID: 21453221 [TBL] [Abstract][Full Text] [Related]
8. [Editorial: Pharmazie in unserer Zeit 5/2011]. Schubert-Zsilavecz M; Högger P Pharm Unserer Zeit; 2011 Sep; 40(5):371. PubMed ID: 22083877 [No Abstract] [Full Text] [Related]
9. The discovery of long-acting saligenin β₂ adrenergic receptor agonists incorporating a urea group. Procopiou PA; Barrett VJ; Ford AJ; Looker BE; Lunniss GE; Needham D; Smith CE; Somers G Bioorg Med Chem; 2011 Oct; 19(20):6026-32. PubMed ID: 21925889 [TBL] [Abstract][Full Text] [Related]
10. Design-driven LO: the discovery of new ultra long acting dibasic β2-adrenoceptor agonists. Connolly S; Alcaraz L; Bailey A; Cadogan E; Christie J; Cook AR; Fisher AJ; Hill S; Humphries A; Ingall AH; Kane Z; Paine S; Pairaudeau G; Stocks MJ; Young A Bioorg Med Chem Lett; 2011 Aug; 21(15):4612-6. PubMed ID: 21723724 [TBL] [Abstract][Full Text] [Related]
11. From libraries to candidate: the discovery of new ultra long-acting dibasic β₂-adrenoceptor agonists. Alcaraz L; Bailey A; Cadogan E; Connolly S; Jewell R; Jordan S; Kindon N; Lister A; Lawson M; Mullen A; Dainty I; Nicholls D; Paine S; Pairaudeau G; Stocks MJ; Thorne P; Young A Bioorg Med Chem Lett; 2012 Jan; 22(1):689-95. PubMed ID: 22079756 [TBL] [Abstract][Full Text] [Related]
12. The in vitro pharmacology of GS-5759, a novel bifunctional phosphodiesterase 4 inhibitor and long acting β2-adrenoceptor agonist. Tannheimer SL; Sorensen EA; Cui ZH; Kim M; Patel L; Baker WR; Phillips GB; Wright CD; Salmon M J Pharmacol Exp Ther; 2014 Apr; 349(1):85-93. PubMed ID: 24513870 [TBL] [Abstract][Full Text] [Related]
13. Discovery of (R)-1-(3-((2-chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate (TD-5959, GSK961081, batefenterol): first-in-class dual pharmacology multivalent muscarinic antagonist and β₂ agonist (MABA) for the treatment of chronic obstructive pulmonary disease (COPD). Hughes AD; Chen Y; Hegde SS; Jasper JR; Jaw-Tsai S; Lee TW; McNamara A; Pulido-Rios MT; Steinfeld T; Mammen M J Med Chem; 2015 Mar; 58(6):2609-22. PubMed ID: 25629394 [TBL] [Abstract][Full Text] [Related]
14. The discovery of long-acting saligenin β₂ adrenergic receptor agonists incorporating hydantoin or uracil rings. Procopiou PA; Barrett VJ; Bevan NJ; Butchers PR; Conroy R; Emmons A; Ford AJ; Jeulin S; Looker BE; Lunniss GE; Morrison VS; Mutch PJ; Perciaccante R; Ruston M; Smith CE; Somers G Bioorg Med Chem; 2011 Jul; 19(14):4192-201. PubMed ID: 21696967 [TBL] [Abstract][Full Text] [Related]
15. The identification of 7-[(R)-2-((1S,2S)-2-benzyloxycyclopentylamino)-1-hydroxyethyl]-4-hydroxybenzothiazolone as an inhaled long-acting β2-adrenoceptor agonist. Arnold N; Beattie D; Bradley M; Brearley A; Brown L; Charlton SJ; Fairhurst RA; Farr D; Fozard J; Fullerton J; Gosling M; Hatto J; Janus D; Jones D; Jordan L; Lewis C; Maas J; McCarthy C; Mercer M; Oakman H; Press N; Profit R; Schuerch F; Sykes D; Taylor RJ; Trifilieff A; Tuffnell A Bioorg Med Chem Lett; 2014 Sep; 24(17):4341-7. PubMed ID: 25065493 [TBL] [Abstract][Full Text] [Related]
16. Long-acting β₂ agonists for asthma: a clinical paradox. Williams D Consult Pharm; 2010 Nov; 25(11):756-9. PubMed ID: 21138824 [TBL] [Abstract][Full Text] [Related]
17. Multivalent dual pharmacology muscarinic antagonist and β₂ agonist (MABA) molecules for the treatment of COPD. Hughes AD; McNamara A; Steinfeld T Prog Med Chem; 2012; 51():71-95. PubMed ID: 22520472 [No Abstract] [Full Text] [Related]
18. [Corticosteroid treatment in airways narrowing]. Chazan R Pneumonol Alergol Pol; 2008; 76(2):96-100. PubMed ID: 18464224 [TBL] [Abstract][Full Text] [Related]
19. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Baker WL; Baker EL; Coleman CI Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942 [TBL] [Abstract][Full Text] [Related]
20. Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules. Hughes AD; Chin KH; Dunham SL; Jasper JR; King KE; Lee TW; Mammen M; Martin J; Steinfeld T Bioorg Med Chem Lett; 2011 Mar; 21(5):1354-8. PubMed ID: 21310610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]